Improved outcome by adding concurrent chemotherapy to Cetuximab and radiotherapy for loaclly advanced head and neck carcinomas: Results of the GORTEC 2007-01 phase III randomized trial
Key Publications on NACT and Targeted therapies in head and neck cancer
Chairpersons :
Alok Thakar, Krishnakumar Thankappan, K. S. Gopinath
Reviewer :
Mohit Sharma